City

Bethesda (1)

Houston (1)

Condition

Central Nervous System Sarcoma (2)

Ependymoma (1)

Glioma (1)

Gliosarcoma (1)

Malignant Intracranial Germ Cell Tumor (1)

Medulloblastoma (1)

Pineoblastoma (1)

Primary Central Nervous System Neoplasm (1)

Overall Status

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

placebo administration (1)

questionnaire administration (1)

sunitinib (1)

wgt3x-bt (1)

wound dressing material (1)

Study Documents

Intervention Type

drug (2)

device (1)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

central nervous system sarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Gliosarcoma, CNS Sarcoma Trial run by the NCI (Sunitinib, wGT3x-BT)

Terminated

Has Results

Gliosarcoma
Central Nervous System Sarcoma

Sunitinib
wGT3x-BT

Bethesda, Maryland

National Institutes of Health Clinical Center

Mar 24, 2022

CNS Sarcoma, Ependymoma, Glioma Trial in Houston (Placebo Administration, Questionnaire Administration, Wound Dressing Material)

Withdrawn

Central Nervous System Sarcoma
+6 more

Placebo Administration
+2 more

Houston, Texas

M D Anderson Cancer Center

Nov 28, 2020